Product Description: 
Cerebrolysin is a peptide complex derived from purified porcine brain proteins, consisting of low molecular weight neuropeptides and free amino acids. It has been studied extensively in European and Asian research settings for its neurotrophic and neuroprotective properties, with a published research history spanning several decades.
 
Current research has explored Cerebrolysin in the following contexts: neurotrophic factor mimetic activity and BDNF, NGF and GDNF pathway simulation, neuroprotection following ischemic and traumatic brain injury models, neurogenesis and synaptic plasticity research, cognitive function and memory consolidation, Alzheimer's disease and neurodegenerative disease models, and stroke recovery and neurorehabilitation research.
 
Why Researchers Are Interested in Cerebrolysin 
Cerebrolysin's multimodal neurotrophic profile — simultaneously mimicking multiple brain growth factors — has made it one of the most studied neuroprotective compounds in Eastern European and Asian clinical research. Its broad mechanism of action across multiple neurological pathways distinguishes it from single-target nootropic compounds.
 
Specifications: 60mg | Lyophilized powder | Purity ≥98% | Store at 2–8°C
 
For Research Use Only. Not intended for human or veterinary use.
 
Structure
Chemical composition and regulatory designation
CAS Number: 12656-61-0
PubChem CID: 472407974
Synonyms: Cerebrolyzin, FPE-1070, Renacenz, 37KZM6S21G
 
NOTE: As a naturally occurring peptide mixture, Cerebrolysin lacks a single molecular structure. The FDA granted it orphan designation for frontotemporal dementia and ALS, reflecting its therapeutic promise in rare neurological diseases.